Dagens Industri SV

Diamyd gör nyemission – utspädning på 11 procent

Styrelsen för Diamyd Medical har beslutat om en riktad emission av drygt 17,2 miljoner aktier till teckningskursen 13,54 kronor, vilket tillför bolaget cirka 233 miljoner kronor före transaktionskostnader. Det framgår av ett pressmeddelande.

Mar 23, 2026 &03312323202631; 07:31 UTC www.di.se Trending 2/5

Read original on www.di.se ↗

→

Neutral impact

Sentiment score: -15/100

Moderate impact Short-term (days)

WHAT THIS MEANS

Diamyd Medical announced a directed share issuance of 17.2 million shares at 13.54 SEK per share, raising approximately 233 million SEK before transaction costs. This represents an 11% dilution to existing shareholders. The capital raise suggests the company needs funding for operations or strategic initiatives.

AI CONFIDENCE

72% High

SENTIMENT GAUGE

NEWS POWER SCORE

AFFECTED ASSETS

↓

DIAMYD.ST

DIAMYD.STStock

Expected to decline

Directed share issuance causes 11% shareholder dilution; stock typically experiences downward pressure on dilutive capital raises unless proceeds fund high-ROI projects

⇅

OMXS30.ST

OMXS30.STIndex

High volatility expected

Minimal impact on broader Swedish index; isolated to small-cap biotech sector

PRICE HISTORY

Loading chart...

⚡ SUGGESTED ACTION

Avoid chasing this stock on the announcement. Monitor for clarification on capital deployment; if proceeds fund clinical trials or acquisitions with clear value creation, reassess. Otherwise, expect near-term selling pressure from dilution-sensitive investors.

KEY SIGNALS

Shareholder dilution of 11%Directed placement (not open offering)233 MSEK capital raise suggests funding needPricing at 13.54 SEK indicates market conditions at time of decisionNo mention of use of proceeds or strategic rationale

SECTORS INVOLVED

Healthcare/BiotechSmall-cap equities

Analysis generated on Mar 23, 2026 at 07:39 UTC

Disclaimer: This analysis is generated by artificial intelligence for informational purposes only and does not constitute financial advice, investment recommendation, or solicitation. Original reporting by Dagens Industri. Always conduct your own research and consult a qualified financial advisor before making investment decisions.

Diamyd gör nyemission – utspädning på 11 procent

RELATED INTELLIGENCE